Abbott Laboratories Started Outperform by Oppenheimer Thanks to Favorable Risk/Reward By Investing.com
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE:) with an Outperform rating and a $130 price target in a ...
Tag: Oppenheimer
ResMed cuts Oppenheimer after Lilly sleep apnea data
Pgiam/iStock via Getty Images Oppenheimer downgraded respiratory device maker ResMed (New York Stock Exchange: RMD) outperformed on Tuesday, citing an ...
Oppenheimer predicts the S&P 500 will end 2024 at 5,200 By Investing.com
© Reuters. Oppenheimer predicts the S&P 500 will end 2024 at 5,200 Oppenheimer Asset Management predicts that strong earnings growth ...
Recommended.
